Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2013

Open Access 01-12-2013 | Research

A comparison of four different approaches to measuring health utility in depressed patients

Authors: Nicholas Turner, John Campbell, Tim J Peters, Nicola Wiles, Sandra Hollinghurst

Published in: Health and Quality of Life Outcomes | Issue 1/2013

Login to get access

Abstract

Background

A variety of instruments are used to measure health related quality of life. Few data exist on the performance and agreement of different instruments in a depressed population. The aim of this study was to investigate agreement between, and suitability of, the EQ-5D-3L, EQ-5D Visual Analogue Scale (EQ-5D VAS), SF-6D and SF-12 new algorithm for measuring health utility in depressed patients.

Methods

The intraclass correlation coefficient (ICC) and Bland and Altman approaches were used to assess agreement. Instrument sensitivity was analysed by: (1) plotting utility scores for the instruments against one another; (2) correlating utility scores and depressive symptoms (Beck Depression Inventory (BDI)); and (3) using Tukey’s procedure. Receiver Operating Characteristic (ROC) analysis assessed instrument responsiveness to change. Acceptability was assessed by comparing instrument completion rates.

Results

The overall ICC was 0.57. Bland and Altman plots showed wide limits of agreement for each pair wise comparison, except between the SF-6D and SF-12 new algorithm. Plots of utility scores displayed ’ceiling effects’ in the EQ-5D-3L index and ’floor effects’ in the SF-6D and SF-12 new algorithm. All instruments showed a negative monotonic relationship with BDI, but the EQ-5D-3L index and EQ-5D VAS could not differentiate between depression severity sub-groups. The SF-based instruments were better able to detect changes in health state over time. There was no difference in completion rates of the four instruments.

Conclusions

There was a lack of agreement between utility scores generated by the different instruments. According to the criteria of sensitivity, responsiveness and acceptability that we applied, the SF-6D and SF-12 may be more suitable for the measurement of health related utility in a depressed population than the EQ-5D-3L, which is the instrument currently recommended by NICE.
Appendix
Available only for authorised users
Literature
1.
NICE. Depression: The treatment and management of depression in adults (CG90). London: HMSO; 2009.
2.
Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL: Methods for the economic evaluation of health care programmes – third edition. New York: Oxford University Press; 2005.
3.
Decision Support Unit NICE: The incorporation of health benefits in cost utility analysis using the EQ-5D. London: HMSO; 2010.
4.
Decision Support Unit NICE: Alternatives to EQ-5D for generating health state utility values. London: HMSO; 2011.
5.
Roberts J, Dolan P: To what extent do people prefer health states with higher values? A note on evidence from the EQ-5D valuation set. Health Econ 2004, 13: 733–737. 10.1002/hec.875PubMedCrossRef
6.
Raisch DW, Feeney P, Goff DC Jr, Narayan KM, O’Connor PJ, Zhang P, Hire DG, Sullivan MD: Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial. Cardiovasc Diabetol 2012, 11: 35. 10.1186/1475-2840-11-35PubMedCentralPubMedCrossRef
7.
Heintz E, Wirehn AB, Peebo BB, Rosenqvist U, Levin LA: QALY weights for diabetic retinopathy – A comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS and TTO. Value Health 2012, 15: 475–484. 10.1016/j.jval.2011.11.031PubMedCrossRef
8.
Bijl RV, Ravelli A: Current and residual functional disability associated with psychopathology: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med 2000, 30: 657–668. 10.1017/S0033291799001841PubMedCrossRef
9.
Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3: 2011–2031.CrossRef
10.
Lamers LM, Bouwmans CAM, Van Straten A, Donker MCH, Hakkart L: Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Econ 2006, 15: 1229–1236. 10.1002/hec.1125PubMedCrossRef
11.
Mann R, Gilbody S, Richards D: Putting the ‘Q’ in depression QALYs: a comparison of utility measurement using EQ-5D and SF-6D health related quality of life measures. Soc Psychiatry Psychiatr Epidemiol 2009, 44: 569–578. 10.1007/s00127-008-0463-5PubMedCrossRef
12.
Gerhards SAH, Huibers MJH, Theunissen KATM, de Graaf LE, Widdershoven GAM, Evers SMAA: The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD). Value Health 2011, 14: 732–739. 10.1016/j.jval.2010.12.004PubMedCrossRef
13.
Brazier JE, Roberts J: The estimation of a preference-based measure of health from the SF-12. Med Care 2004, 42: 851–859. 10.1097/01.mlr.0000135827.18610.0dPubMedCrossRef
14.
Thomas LJ, Abel A, Ridgway N, Peters T, Kessler D, Hollinghurst S, Turner K, Garland A, Jerrom B, Morrison J, Williams C, Campbell J, Kuyken W, Lewis G, Wiles N: Cognitive Behavioural Therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: the CoBalT randomised controlled trial protocol. Contemp Clin Trials 2012, 33: 312–319. 10.1016/j.cct.2011.10.016PubMedCrossRef
15.
Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33: 337–343. 10.3109/07853890109002087PubMedCrossRef
16.
Dolan P: Modelling valuations for EuroQol health states. Med Care 1997, 35: 1095–1108. 10.1097/00005650-199711000-00002PubMedCrossRef
17.
Parkin D, Devlin N: Is there a case for using visual analogue scale valuations in cost-utility analysis? Health Econ 2006, 15: 653–664. 10.1002/hec.1086PubMedCrossRef
18.
Brazier J, Roberts J, Deverill M: The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002, 21: 271–292. 10.1016/S0167-6296(01)00130-8PubMedCrossRef
19.
Beck A, Steer RA, Brown GK: Beck Depression Inventory – Second Edition. San Anotonio: The Psychological Corporation; 1996.
20.
Lewis G, Pelosi AJ, Araya R, Dunn G: Measuring psychiatric disorder in the community: a standardized assessment for lay interviewers. Psychol Med 1992, 22: 465–486. 10.1017/S0033291700030415PubMedCrossRef
21.
Ware JE, Kolinski M, Keller SD: How to score the SF-12 Physical and Mental Health Summaries: A User’s Manual. Boston: The Health Institute, New England Medical Centre, Boston, MA; 1995.
22.
Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 327: 307–310. 10.1016/S0140-6736(86)90837-8CrossRef
23.
Longworth L, Bryan S: An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ 2003, 12: 1061–1067. 10.1002/hec.787PubMedCrossRef
24.
Petrou S, Hockley C: An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Econ 2005, 14: 1169–1189. 10.1002/hec.1006PubMedCrossRef
25.
Brazier J, Deverill M, Green C, Harper R, Booth A: A review of the use of health status measures in economic evaluation. Health Technol Assess 1999, 3: 1–164.
26.
Kramer CY: Extension of multiple range tests to group means with unequal number of replications. Biometrics 1956, 12: 307–310. 10.2307/3001469CrossRef
27.
Sahei H, Ageel MI: The Analysis of Variance: Fixed, Random and Mixed Models. Boston: Birkhauser; 2000.CrossRef
28.
Stucki G, Liang MH, Fossel AH, Katz JN: Relative responsiveness of condition-specific and general health status measures in degenerative lumbar spinal stenosis. J Clin Epidemiol 1995, 48: 1369–1378. 10.1016/0895-4356(95)00054-2PubMedCrossRef
29.
Husted JA, Cook RJ, Farewell VT, Gladman DD: Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 2000, 53: 459–468. 10.1016/S0895-4356(99)00206-1PubMedCrossRef
30.
DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operator characteristic curves: a nonparametric approach. Biometrics 1998, 44: 837–845.CrossRef
31.
Gerrard K, Nicholson T, Mullee M, Mehta R, Roderick P: EQ-5D versus SF-6D in an older, chronically ill patient group. Appl Health Econ Health Policy 2004, 3: 91–102. 10.2165/00148365-200403020-00005CrossRef
32.
Barton GR, Sach TH, Avery AJ, Jenkinson C, Doherty M, Whynes DK, Muir KR: A comparison of the performance of the EQ-5D and SF-6D for individuals aged ≥ 45 years. Health Econ 2008, 17: 815–832. 10.1002/hec.1298PubMedCrossRef
33.
34.
Glass GV, Hopkins BK: Statistical methods in education and psychology – third edition. Boston: Allyn and Bacon; 1996.
35.
Brazier J, Roberts J, Tsuchiya A, Busschbach J: A comparison of the EQ-5D and the SF-6D across seven patient groups. Health Econ 2004, 13: 873–884. 10.1002/hec.866PubMedCrossRef
36.
Kopec JA, Willison KD: A comparative review of four preference-weighted measures of health-related quality of life. J Clin Epidemiol 2003, 56: 317–325. 10.1016/S0895-4356(02)00609-1PubMedCrossRef
37.
Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M: Evaluation of outcomes with citalopram for depression using measurment-based care in STAR*D: Implications for clinical practice. Am J Psychiatry 2006, 163: 28–40. 10.1176/appi.ajp.163.1.28PubMedCrossRef
38.
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X: Development and preliminary testing of the new five-level version of the EQ-5D (EQ-5D-5L). Qual Life Res 2011, 20: 1727–1736. 10.1007/s11136-011-9903-xPubMedCentralPubMedCrossRef
Metadata
Title
A comparison of four different approaches to measuring health utility in depressed patients
Authors
Nicholas Turner
John Campbell
Tim J Peters
Nicola Wiles
Sandra Hollinghurst
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2013
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-11-81

Other articles of this Issue 1/2013

Health and Quality of Life Outcomes 1/2013 Go to the issue

Research

Construct validity of the Assessment of Quality of Life - 6D (AQoL-6D) in community samples

Research

Quality of life in China rural-to-urban female migrant factory workers: a before-and-after study

Research

Testing the McSad depression specific classification system in patients with somatic conditions: validity and performance

Research

Self-rated quality of life of city-dwelling elderly people benefitting from social help: results of a cross-sectional study

Erratum

Erratum to: systematic review: do patient expectations influence treatment outcomes in total knee and total hip arthroplasty?

Research

Construction and validation of a measure of integrative well-being in seven languages: The Pemberton Happiness Index